Evidence map›Paper›PMID 37468760›Full record

ArticleCommunications biology2023

Identifying dysregulated immune cell subsets following volumetric muscle loss with pseudo-time trajectories.

Lauren A Hymel, Shannon E Anderson, Thomas C Turner, William Y York, Hongmanlin Zhang, Adrian R Liversage, Hong Seo Lim, Peng Qiu, Luke J Mortensen, Young C Jang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Lauren A Hymel *Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID 0000-0002-6749-8486
Shannon E Anderson *Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Thomas C TurnerDepartment of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
William Y YorkDepartment of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Hongmanlin ZhangPetit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, USA.
Adrian R LiversageSchool of Chemical, Materials, and Biomedical Engineering, University of Georgia, Athens, GA, USA.ORCID 0000-0003-0608-1078
Hong Seo LimDepartment of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Peng QiuDepartment of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID 0000-0003-3256-0734
Luke J MortensenSchool of Chemical, Materials, and Biomedical Engineering, University of Georgia, Athens, GA, USA.
Young C JangDepartment of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA. young.jang@emory.edu.ORCID 0000-0002-9489-2104
Nick J WillettPetit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, USA. nwillett@uoregon.edu.ORCID 0000-0003-3421-2549
Edward A BotchweyDepartment of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA. edward.botchwey@bme.gatech.edu.ORCID 0000-0003-1140-5786
Georgia Institute of Technology · USUniversity of Georgia · US

Funding

Research Training Program Plan on Cell and Tissue Engineering (CTEng)T32GM008433 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI GARCIA, ANDRES J · 1991 to 2021
$7.1M
Hydrogels for hMSC delivery & engraftmentR01AR062368 · NIAMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI GARCIA, ANDRES J · 2012 to 2022
$3.5M
Artery biomechanics and vascular damage in sickle cell diseaseR01HL158159 · NHLBI · GEORGIA INSTITUTE OF TECHNOLOGY · PI BOTCHWEY, EDWARD A. · 2021 to 2024
$2.3M
Engineering the Immune and Fibrotic Response in Volumetric Muscle LossR01AR078375 · NIAMS · UNIVERSITY OF OREGON · PI WILLETT, NICK J · 2021 to 2025
$1.8M
Regenerative Immunotherapy using light triggered in vivo activation of adhesive peptidesR56DE029703 · NIDCR · GEORGIA INSTITUTE OF TECHNOLOGY · PI BOTCHWEY, EDWARD A., GARCIA, ANDRES J · 2020 to 2020
$430k
Combined Regenerative and Rehabilitation Therapies for Extremity TraumaI01RX001985 · VA · VETERANS HEALTH ADMINISTRATION · PI WILLETT, NICK J · 2019 to 2024
–
NHLBI NIH HHS R01 HL158159NIAMS NIH HHS R01 AR062368NIAMS NIH HHS R01 AR078375NIDCR NIH HHS R56 DE029703NIGMS NIH HHS T32 GM008433RRD VA I01 RX001985
6 · The paper itself

Abstract

Volumetric muscle loss (VML) results in permanent functional deficits and remains a substantial regenerative medicine challenge. A coordinated immune response is crucial for timely myofiber regeneration, however the immune response following VML has yet to be fully characterized. Here, we leveraged dimensionality reduction and pseudo-time analysis techniques to elucidate the cellular players underlying a functional or pathological outcome as a result of subcritical injury or critical VML in the murine quadriceps, respectively. We found that critical VML resulted in a sustained presence of M2-like and CD206

Indexed as

Muscle, SkeletalMuscular DiseasesAnimalsCollagenMiceRegenerationRegenerative MedicineCollagen

Identifiers

PMID37468760
PMCPMC10356763
OpenAlexW4384818857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.